OOIR: Observatory of International Research

Papers

(The H4-Index of Sleep is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Performance of seven consumer sleep-tracking devices compared with polysomnography	179
Metrics of sleep apnea severity: beyond the apnea-hypopnea index	153
The Dreem Headband compared to polysomnography for electroencephalographic signal acquisition and sleep staging	150
A workshop report on the causes and consequences of sleep health disparities	116
Detecting sleep using heart rate and motion data from multisensor consumer-grade wearables, relative to wrist actigraphy and polysomnography	91
COVID-19-related mobility reduction: heterogenous effects on sleep and physical activity rhythms	84
Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE 2	80
A standardized framework for testing the performance of sleep-tracking technology: step-by-step guidelines and open-source code	78
Sleep and mental health in athletes during COVID-19 lockdown	77
The effect of sleep deprivation and restriction on mood, emotion, and emotion regulation: three meta-analyses in one	71
Deep learning enables sleep staging from photoplethysmogram for patients with suspected sleep apnea	70
Prospective examination of adolescent sleep patterns and behaviors before and during COVID-19	69
Randomized clinical trials of cardiovascular disease in obstructive sleep apnea: understanding and overcoming bias	69
Limiting racial disparities and bias for wearable devices in health science research	66
Obstructive sleep apnea treatment and dementia risk in older adults	65
Individual differences in light sensitivity affect sleep and circadian rhythms	64
Digital cognitive behavioral therapy for insomnia promotes later health resilience during the coronavirus disease 19 (COVID-19) pandemic	62
Gender differences in nighttime sleep patterns and variability across the adult lifespan: a global-scale wearables study	62
Video-polysomnography procedures for diagnosis of rapid eye movement sleep behavior disorder (RBD) and the identification of its prodromal stages: guidelines from the International RBD Study Group	61
To split or to lump? Classifying the central disorders of hypersomnolence	59
Telemedicine versus face-to-face delivery of cognitive behavioral therapy for insomnia: a randomized controlled noninferiority trial	57
Measuring sleep regularity: theoretical properties and practical usage of existing metrics	54
Prevalent, incident, and persistent insomnia in a population-based cohort tested before (2018) and during the first-wave of COVID-19 pandemic (2020)	53
The social and economic cost of sleep disorders	50
Workshop report. Circadian rhythm sleep–wake disorders: gaps and opportunities	49

Automatic sleep staging using heart rate variability, body movements, and recurrent neural networks in a sleep disordered population	46
Automatic sleep stage classification with deep residual networks in a mixed-cohort setting	44
Electroencephalographic changes associated with subjective under- and overestimation of sleep duration	43
Predicting circadian misalignment with wearable technology: validation of wrist-worn actigraphy and photometry in night shift workers	42
The natural history of insomnia: predisposing, precipitating, coping, and perpetuating factors over the early developmental course of insomnia	41
Prevalence rates and correlates of insomnia disorder in post-9/11 veterans enrolling in VA healthcare	41
Expert-level automated sleep staging of long-term scalp electroencephalography recordings using deep learning	40
The effect of zolpidem on memory consolidation over a night of sleep	40
Susceptibility to auditory closed-loop stimulation of sleep slow oscillations changes with age	39
Changes of evening exposure to electronic devices during the COVID-19 lockdown affect the time course of sleep disturbances	39
Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcol	38
Evening-types show highest increase of sleep and mental health problems during the COVID-19 pandemic—multinational study on 19 267 adults	37
The prevalence of common sleep disorders in young adults: a descriptive population-based study	37
A randomized controlled trial of CBT-I and PAP for obstructive sleep apnea and comorbid insomnia: main outcomes from the MATRICS study	37